{"drugs":["Elestat","Epinastine Hydrochloride"],"mono":{"0":{"id":"927952-s-0","title":"Generic Names","mono":"Epinastine Hydrochloride"},"1":{"id":"927952-s-1","title":"Dosing and Indications","sub":{"0":{"id":"927952-s-1-4","title":"Adult Dosing","mono":"<b>Allergic conjunctivitis:<\/b> 1 drop of 0.05% solution in each EYE twice daily throughout period of allergen exposure, even when symptoms are absent "},"1":{"id":"927952-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy not established in pediatric patients under 2 years of age<\/li><li><b>Allergic conjunctivitis:<\/b> (2 years and older) 1 drop of 0.05% solution in each EYE twice daily throughout period of allergen exposure, even when symptoms are absent<\/li><\/ul>"},"3":{"id":"927952-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Allergic conjunctivitis<br\/>"}}},"3":{"id":"927952-s-3","title":"Contraindications\/Warnings","sub":[{"id":"927952-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"927952-s-3-10","title":"Precautions","mono":"<ul><li>contact lens-related irritation; use not recommended<\/li><li>soft contact lens use; benzalkonium chloride preservative may be absorbed by lenses; remove contact lenses prior to administration and wait 10 minutes before reinserting lenses<\/li><li>report suspected adverse events to the US Food and Drug Administration at 1-800-433-8871 or www.fda.gov\/medwatch<\/li><\/ul>"},{"id":"927952-s-3-11","title":"Pregnancy Category","mono":"Epinastine: C (FDA)<br\/>"},{"id":"927952-s-3-12","title":"Breast Feeding","mono":"Epinastine: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"927952-s-4","title":"Drug Interactions","sub":{"1":{"id":"927952-s-4-14","title":"Major","mono":"<ul><li>Bupropion (theoretical)<\/li><li>Donepezil (theoretical)<\/li><\/ul>"}}},"5":{"id":"927952-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Erythema, Pruritus<\/li><li><b>Neurologic:<\/b>Headache<\/li><li><b>Ophthalmic:<\/b>Burning sensation in eye, Follicular conjunctivitis, acute<\/li><li><b>Respiratory:<\/b>Common cold, Increasing frequency of cough, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory infection<\/li><\/ul>"},"6":{"id":"927952-s-6","title":"Drug Name Info","sub":{"0":{"id":"927952-s-6-17","title":"US Trade Names","mono":"Elestat<br\/>"},"2":{"id":"927952-s-6-19","title":"Class","mono":"<ul><li>Antihistamine, Less-Sedating<\/li><li>Ophthalmologic Agent<\/li><\/ul>"},"3":{"id":"927952-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"927952-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"927952-s-7","title":"Mechanism Of Action","mono":"Epinastine hydrochloride is an antihistamine and an inhibitor of histamine release from the mast cell. It is selective for the histamine H(1)-receptor and has affinity for histamine H(2)-, gamma(1)-, gamma(2)-, and 5-HT(2) receptors <br\/>"},"8":{"id":"927952-s-8","title":"Pharmacokinetics","sub":[{"id":"927952-s-8-23","title":"Absorption","mono":"Oral: time to peak concentration, about 2 h<br\/>"},{"id":"927952-s-8-24","title":"Distribution","mono":"Protein binding: 64% <br\/>"},{"id":"927952-s-8-25","title":"Metabolism","mono":"less than 10% metabolized <br\/>"},{"id":"927952-s-8-26","title":"Excretion","mono":"<ul><li>Fecal: (IV), 30% as unchanged<\/li><li>Renal: (IV), 55% unchanged, mainly via active tubular secretion<\/li><\/ul>"},{"id":"927952-s-8-27","title":"Elimination Half Life","mono":"about 12 h <br\/>"}]},"9":{"id":"927952-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>for topical ophthalmic use only; not for injection or oral use<br\/><\/li><li><b>Ophthalmic<\/b><br\/>remove contact lenses prior to instillation; may reinsert 10 minutes following epinastine administration<br\/><\/li><\/ul>"},"10":{"id":"927952-s-10","title":"Monitoring","mono":"reduction in ocular itching and irritation<br\/>"},"11":{"id":"927952-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Ophthalmic Solution: 0.05 %<br\/><\/li><li><b>Elestat<\/b><br\/>Ophthalmic Solution: 0.05 %<br\/><\/li><\/ul>"},"13":{"id":"927952-s-13","title":"Clinical Teaching","mono":"<ul><li>Advise patients to not wear contact lens if eye is red.<\/li><li>This drug may cause headache, burning sensation in eye, follicular conjunctivitis, or signs\/symptoms of a common cold.<\/li><li>Instruct patient on proper instillation technique.<\/li><li>Advise patient to remove contact lenses prior to instilling drug. Lenses may be reinserted 10 min following instillation.<\/li><\/ul>"}}}